See Full Document Text
Official Journal EN
of the European Union L series
2026/1765 16.7.2026
COMMISSION IMPLEMENTING DECISION(EU) 2026/1765
of 14 July 2026
amending the Annexes to Implementing Decision (EU) 2025/1582 concerning certain emergency
measures relating to infection with lumpy skin disease virus in Italy
(notified under document C(2026) 5039)
(Only the Italian text is authentic)
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on
transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health
Law’)(1), and in particular Article 259(1) thereof,
Whereas:
(1) Infection with lumpy skin disease virus is an infectious, vector-borne disease affecting bovine animals. Its occurrence
can have a severe impact on the concerned animal population and on the profitability of farming, also causing
disturbance to movements of those animals and products thereof within the Union and exports to third countries. In
the event of an outbreak of an infection with lumpy skin disease virus in bovine animals, there is a serious risk of the
spread of that disease to other establishments keeping bovine animals, particularly due its main mode of transmission
through vectors.
(2) Commission Delegated Regulation (EU) 2020/687(2) supplements the rules for the control of the listed diseases
referred to in Article 9(1), points (a), (b) and (c), of Regulation (EU) 2016/429, and defined as category A, B and C
diseases in Commission Implementing Regulation (EU) 2018/1882(3). In particular, Articles 21 and 22 of Delegated
Regulation (EU) 2020/687 provide for the establishment of a restricted zone in the event of an outbreak of a category
A disease, including infection with lumpy skin disease virus, and for certain measures to be applied therein. In
addition, Article 21(1) of that Delegated Regulation provides that the restricted zone is to comprise at least a
protection zone, a surveillance zone, and, if necessary, further restricted zones around or adjacent to the protection
and surveillance zones.
(3) Commission Implementing Decision (EU) 2025/1582(4)lays down certain emergency measures related to outbreaks
of infection with lumpy skin disease virus in Italy. Article 1 of Implementing Decision (EU) 2025/1582 provides for
the establishment, in Italy, of restricted zones, comprising protection and surveillance zones, in accordance with
Article 21 of Delegated Regulation (EU) 2020/687, as well as the establishment of vaccination zones, in accordance
(1) OJ L 84, 31.3.2016, p. 1, ELI: http://data.europa.eu/eli/reg/2016/429/oj.
(2) Commission Delegated Regulation (EU) 2020/687 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European
Parliament and the Council, as regards rules for the prevention and control of certain listed diseases (OJ L 174, 3.6.2020, p. 64, ELI:
http://data.europa.eu/eli/reg_del/2020/687/oj).
(3) Commission Implementing Regulation (EU) 2018/1882 of 3 December 2018 on the application of certain disease prevention and
control rules to categories of listed diseases and establishing a list of species and groups of species posing a considerable risk for the
spread of those listed diseases (OJ L 308, 4.12.2018, p. 21, ELI: http://data.europa.eu/eli/reg_impl/2018/1882/oj).
(4) Commission Implementing Decision (EU) 2025/1582 of 29 July 2025 concerning certain emergency measures relating to infection
with lumpy skin disease virus in Italy and repealing Implementing Decision (EU) 2025/1318 (OJ L, 2025/1582, 1.8.2025, ELI: http://
data.europa.eu/eli/dec_impl/2025/1582/oj).
ELI: http://data.europa.eu/eli/dec_impl/2026/1765/oj 1/5EN
OJ L, 16.7.2026
with Part 1 of Annex IX to Commission Delegated Regulation (EU) 2023/361(5). In addition, Article 1 of
Implementing Decision (EU) 2025/1582 provides that those protection and surveillance zones, as well as the
vaccination zones, are to comprise at least the areas listed in Annexes I and II thereto, and the measures required to
be applied in those zones are to be applied at least until the dates set out in those Annexes.
(4) The size of the areas indicated as protection and surveillance zones in Annex I to Implementing Decision
(EU) 2025/1582, as amended by this Decision, as well as the duration of the measures to be applied therein, are
based on the criteria laid down in Article 64(1) of Regulation (EU) 2016/429, as well as on the rules laid down in
Delegated Regulation (EU) 2020/687. The criteria applied for the choice of the size of the protection and
surveillance zones, as well as of the duration of the measures to be applied therein, include the consideration of not
only the epidemiological situation as regards infection with lumpy skin disease virus in the areas affected by that
disease, but also of other epidemiological factors, including geographical parameters and the risk for the further
spread of the disease in view of the presence of insect vectors. The chosen duration of the measures provided for in
this Decision has also taken into account the international standards of the Terrestrial Animal Health Code of the
World Organisation for Animal Health(6).
(5) Since the last amendment of Implementing Decision (EU) 2025/1582 by Commission Implementing Decision
(EU) 2026/1355(7), Italy has notified the Commission of an outbreak of infection with lumpy skin disease virus in
an establishment keeping bovine animals, in Samugheo municipality, in the region of Sardinia, which was reported
on 9 July 2026. In response to this outbreak, Italy has established protection and surveillance zones in the region of
Sardinia, where the disease control measures laid down in Delegated Regulation (EU) 2020/687 are applied.
(6) Italy has also notified the Commission, as regards the outbreak that was confirmed in Escalaplano municipality in the
region of Sardinia, of continued delays in the implementation of the disease control measures required to be applied
in the event of official confirmation of an outbreak of a category A disease in kept animals in an establishment in
accordance with Article 12 of Delegated Regulation (EU) 2020/687.
(7) In light of the current epidemiological situation as regards infection with lumpy skin disease virus in Italy, and the
urgent need to effectively mitigate the risk of the spread of that disease, both within that Member State and to other
Member States, it is crucial to amend the duration of the disease control measures applicable in the protection and
surveillance zones for Italy listed in the Annex to Implementing Decision (EU) 2025/1582. This amendment
addresses the significant risk posed by the continued circulation and potential spread of the disease beyond the
currently affected areas as long as the disease control measures have not been completed.
(8) Article 2 of Implementing Decision (EU) 2025/1582 prohibits the movements of bovine animals from the protection
and surveillance zones set out in Annex I to that Implementing Decision to destinations outside the external
perimeter of those zones in Italy or outside that Member State until the dates listed in that Annex. In view of the
currently existing restricted zone in the region of Sardinia, that prohibition should continue to apply in the
protection and surveillance zones established in Implementing Decision (EU) 2025/1582, as amended by this
Decision.
(5) Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European
Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and
control of certain listed diseases (OJ L 52, 20.2.2023, p. 1, ELI: http://data.europa.eu/eli/reg_del/2023/361/oj).
(6) https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/.
(7) Commission Implementing Decision (EU) 2026/1355 of 12 June 2026 amending the Annexes to Implementing Decision
(EU) 2025/1582 concerning certain emergency measures relating to infection with lumpy skin disease virus in Italy (OJ L, 2026/1355,
16.6.2026, ELI: http://data.europa.eu/eli/dec_impl/2026/1355/oj).
2/5 ELI: http://data.europa.eu/eli/dec_impl/2026/1765/ojEN
OJ L, 16.7.2026
(9) The vaccination zones established in Implementing Decision (EU) 2025/1582 remain necessary, and vaccination
should continue in accordance with Italy’s official vaccination plan dated 1 July 2025, which was submitted
pursuant to Article 6(4), point (a), of Delegated Regulation (EU) 2023/361.
(10) The Annexes to Implementing Decision (EU) 2025/1582 should, therefore, be amended accordingly.
(11) In light of the epidemiological situation in Italy, the amendments to be made to Implementing Decision
(EU) 2025/1582 by this Decision should apply as soon as possible, to prevent the further spread of the disease
within Italy, to other Member States or to third countries, and to avoid any unnecessary disturbance to trade within
the Union or unjustified barriers to trade with third countries.
(12) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants,
Animals, Food and Feed,
HAS ADOPTED THIS DECISION:
Article 1
The Annexes to Implementing Decision (EU) 2025/1582 are replaced by the text set out in the Annex to this Decision.
Article 2
This Decision is addressed to the Italian Republic.
Done at Brussels, 14 July 2026.
For the Commission
Olivér VÁRHELYI
Member of the Commission
ELI: http://data.europa.eu/eli/dec_impl/2026/1765/oj 3/5EN
OJ L, 16.7.2026
ANNEX
‘ANNEX I
Protection and surveillance zones established around the confirmed outbreaks
Administrative area and ADIS Areas established as protection and surveillance zones,
Date until applicable
reference number of the outbreak part of the restricted zone, referred to in Article 1
Protection zone:
Those parts of the region of Sardinia, contained
within a circle of a radius of 20 kilometres, centred
on UTM 30, ETRS89 coordinates Lat. 39.33943,
Long. 9.566 (2026/1); Lat. 39.428312, Long.
9.613409 (2026/3); Lat. 39.5677, Long. 9.40683
(2026/4); Lat. 39.346275, Long. 9.573985 14.8.2026
(2026/5); Lat. 39.33754, Long. 9.547191 (2026/6);
Lat. 39.50748, Long. 9.5853 (2026/7) Lat.
39.4034, Long.9.6023 (2026/8); Lat. 39.52927,
Long, 9.57144 (2026/9); Lat. 39.62135, Long, 9
9.34454 (2026/10); Lat.39.9727, Long 8.95929
(2026/11)
Surveillance zone:
Those parts of the region of Sardinia, contained
Sardinia region
within a circle of a radius of 20 kilometres, centred
IT-LSD-2026-00001
on UTM 30, ETRS89 coordinates Lat. 39.33943,
IT-LSD-2026-00003
Long. 9.566 (2026/1); Lat. 39.428312, Long.
IT-LSD-2026-00004
9.613409 (2026/3); Lat. 39.5677, Long. 9.40683
IT-LSD-2026-00005
(2026/4); Lat. 39.346275, Long. 9.573985 15.8.2026 - 31.8.2026
IT-LSD-2026-00006
(2026/5); Lat. 39.33754, Long. 9.547191 (2026/6);
IT-LSD-2026-00007
Lat. 39.50748, Long. 9.5853 (2026/7), Lat.
IT-LSD-2026-00008
39.4034, Long.9.6023 (2026/8); Lat. 39.52927,
IT-LSD-2026-00009
Long, 9.57144(2026/9); Lat. 39.62135, Long, 9
IT-LSD-2026-00010
9.34454 (2026/10), Lat.39.9727, Long 8.95929
IT-LSD-2026-00011
(2026/11);
Surveillance zone:
Those parts of the region of Sardinia, contained
within a circle of a radius of 50 kilometres, centred
on UTM 30, ETRS89 coordinates Lat. 39.33943,
Long. 9.566 (2026/1); Lat. 39.428312, Long.
9.613409 (2026/3); Lat. 39.5677, Long. 9.40683
(2026/4); Lat. 39.346275, Long. 9.573985
31.8.2026
(2026/5); Lat. 39.33754, Long. 9.547191 (2026/6);
Lat. 39.50748, Long. 9.5853 (2026/7), Lat.
39.4034, Long.9.6023 (2026/8); Lat. 39.52927,
Long, 9.57144(2026/9); Lat. 39.62135, Long, 9
9.34454 (2026/10), Lat.39.9727, Long 8.95929
(2026/11), excluding the areas included in the
protection zone.
4/5 ELI: http://data.europa.eu/eli/dec_impl/2026/1765/ojEN
OJ L, 16.7.2026
ANNEX II
Part A: Vaccination zone II
The entire territory of:
— the region of Sardinia until last day of the recovery period, referred to in Part 4 of Annex IX to Delegated Regulation
(EU) 2023/361.
Part B: Vaccination zone I
The entire territory of:
— the region of Valle D’Aosta until last day of the recovery period, referred to in Part 4 of Annex IX to Delegated
Regulation (EU) 2023/361.’
ELI: http://data.europa.eu/eli/dec_impl/2026/1765/oj 5/5